Search Results 1831-1840 of 18811 for Relapse
Have histologically or cytological confirmed diagnosis of relapsed or refractory, advanced and/or metastatic NSCLC, EC, UC, TNBC, SCCHN, or cervical cancer who ...
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...
Stage 2: Enroll up to an additional 23 participants with previously untreated or relapsed or refractory T-PLL. Participation eligibility. Participant ...
- All Parts: Participants must have disease that is relapsed, refractory, or intolerant to standard of care. Participants must have histologically or ...
It detects the presence of miniscule amounts of disease, with implications for relapse and predicted duration of clinical remission. Beta-2-microglobulin ...
... Relapsed Lymphoma. Clin Lymphoma Myeloma Leuk. 2018 Oct; 18 (10):664-672.e2 Epub 2018 June 15. View PubMed; Shanavas M, Popat U, Michaelis LC, Fauble V ...
Transplantation was performed at least 6 months prior to the relapse of HCC. ii. Patients are on stable immune suppressive therapy with no clinical evidence ...
Participants must have relapsed, refractory, or progressive disease, and should have no appropriate standard therapy available at the time of enrollment in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.